Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Accumulated Expenses: 2016-2024

Historic Other Accumulated Expenses for KalVista Pharmaceuticals (KALV) over the last 6 years, with Apr 2024 value amounting to $253,000.

  • KalVista Pharmaceuticals' Other Accumulated Expenses was N/A to $693,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $693,000, marking a year-over-year change of. This contributed to the annual value of $253,000 for FY2024, which is N/A change from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Other Accumulated Expenses stood at $253,000 for FY2024, which was up 97.66% from $128,000 recorded in FY2020.
  • KalVista Pharmaceuticals' Other Accumulated Expenses' 5-year high stood at $253,000 during FY2024, with a 5-year trough of $128,000 in FY2020.
  • For the 1-year period, KalVista Pharmaceuticals' Other Accumulated Expenses averaged around $253,000, with its median value being $253,000 (2024).
  • Data for KalVista Pharmaceuticals' Other Accumulated Expenses shows a maximum YoY crashed of 71.36% (in 2020) over the last 5 years.
  • KalVista Pharmaceuticals' Other Accumulated Expenses (Yearly) stood at $128,000 in 2020, then followed by $253,000 in 2024.